NEPHROPLUS

Nephrocare Health Services Limited · NSE · INE428V01029 · 196 sessions on record

₹648.95▼ −10.80 · −1.6%from ₹659.75 the session before · 1 Oct 2026 close · NSE end of day

Open: ₹661.95
High: ₹662.00
Low: ₹636.85
Day's range: ₹253.8% of the previous close
VWAP: ₹646.91close +0.32% from it
Volume, shares: 2.4 L0.33× the 20-session average
Turnover, ₹ crore: 15
Trades: 15,00016 shares per trade
Previous close: ₹659.75−10.80 to the close
Price band, next session: ₹584.05 – ₹713.8510% either side of the close · dynamic, widened in 5% steps when hit

Day range48% of the way up

₹636.85₹662.00

52-week range60% of the way up

₹446.00 19 Dec₹781.50 11 Sept

−17% from the high · +46% from the low

Futures and options

No derivatives listed on NEPHROPLUS

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it

196 sessions on file · from 17 Dec

NEPHROPLUS close
Nifty 50, rebased

Session read · latest close: 1 Oct 2026
Close ₹ · day %: ₹648.95▼ −1.6% on the previous close
Against Nifty 50: Nifty −0.9%−0.8 pp difference on the day
Against the averages: below 20 · below 5020-session ₹717.43 (−9.5%) · 50-session ₹701.51 (−7.5%)
Volume: 0.33×the previous 20 sessions · 2.4 L shares
Extremes on the day: none

Quarterly results

consolidated · latest filed 11 Aug, 08:26 pm IST · NSE filings

Revenue ₹282 cr; profit ₹32 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session

Quarterly results of NEPHROPLUS on the consolidated basis with the market's move on the first session after each filing
Quarter	Revenue ₹ cr	Revenue YoY	Profit ₹ cr	Profit YoY	EPS ₹	Market on the day
Jun 2026filed 11 Aug	₹282 cr	—	₹32 cr	—	3.11	▼ −4.7%Nifty −0.1% · −4.5 pp
Mar 2026filed 19 May · audited	₹266 cr	—	₹30 cr	—	2.96	▼ −5.5%Nifty +0.2% · −5.7 pp

Fundamentals

consolidated · filings to Jun 2026 · close ₹648.95 on 1 Oct

5.8 times book value, market cap ₹6,500 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing

Market cap: ₹6,500 cron 1 Oct · free float ₹2,400 cr
Price to earnings: —fewer than four consecutive quarters filed
Trailing EPS: —fewer than four consecutive quarters filed
Price to book: 5.8consolidated · balance sheet to Mar 2026
Book value a share: ₹111.03consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity: 0.07borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity: —needs two filed balance sheets
Dividend yield: —no dividend with an ex-date in 365 days
Face value: ₹2a share
Shares outstanding: 10 cron 1 Oct

Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated

Revenue, trailing 12 months: —fewer than four consecutive quarters filed
Revenue growth, 12 months: —needs eight consecutive quarters filed
Revenue 3-year CAGR: —needs twelve consecutive quarters filed
Profit, trailing 12 months: —fewer than four consecutive quarters filed
Profit growth, 12 months: —needs eight consecutive quarters filed
Profit 3-year CAGR: —needs twelve consecutive quarters filed

PeersBSE sub-group Healthcare Service Provider · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap

Stocks in the BSE sub-group Healthcare Service Provider with market cap, price to earnings and price to book
Stock	Market cap ₹	P/E	P/B	Close ₹
LALPATHLABDr. Lal Path Labs Ltd.	34,000 cron 1 Oct	—	13	₹2,005.10
VIJAYAVijaya Diagnostic Centre Limited	15,000 cron 1 Oct	—	15	₹1,428.00
METROPOLISMetropolis Healthcare Limited	11,000 cron 1 Oct	—	7.3	₹537.90
THYROCAREThyrocare Technologies Limited	8,500 cron 1 Oct	—	14	₹533.60
NEPHROPLUSNephrocare Health Services Limited	6,500 cron 1 Oct	—	5.8	₹648.95
SURAKSHASuraksha Diagnostic Limited	1,800 cron 1 Oct	—	7.5	₹350.15
KRSNAAKrsnaa Diagnostics Limited	1,800 cron 1 Oct	—	1.8	₹554.85
3BBLACKBIO3B Blackbio Dx Limited	1,400 cron 1 Oct	—	—	₹1,646.80
ONEGLOBALOne Global Service Provider Limited	1,000 cron 1 Oct	—	—	₹525.40
HEALTHXHealth X Platform Limited	870 cron 1 Oct	—	1.1	₹273.00
GAUDIUMIVFGaudium IVF and Women Health Limited	800 cron 1 Oct	—	5.2	₹109.50

Shareholding

quarter to 30 Jun · none pledged · NSE filings

Promoters hold 63.9%, foreign portfolio investors 8.8%, mutual funds 3.2% and insurance companies 1.2%, as filed for the quarter to 30 Jun.

63.9%12.2%

By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file

Shareholding of NEPHROPLUS by category over the last 2 quarters with the change against the previous quarter
Category	30 Jun	31 Mar
Promoters	63.850.00 pp	63.85
Foreign portfolio investors	8.78▼ −1.16 pp	9.94
Mutual funds	3.20▲ +0.03 pp	3.17
Insurance companies	1.21▼ −0.29 pp	1.50
Banks and financial institutions	4.64▲ +0.67 pp	3.97
Individual investors	6.10▲ +0.67 pp	5.43
Bodies corporate	0.75▲ +0.06 pp	0.69
Other foreign holders	10.95▼ −0.01 pp	10.96
Others	0.52▲ +0.03 pp	0.49

Corporate actions

NSE and BSE records

No corporate action on record for NEPHROPLUS yet.

Price history

196 sessions on record · to 1 Oct · NSE end of day

NEPHROPLUS is −6.3% over 20 sessions against Nifty's −6.2%, 17% below its 52-week high, realised volatility 36% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions

Returns of the stock and Nifty 50 over six windows, longest first
Window	From ₹	NEPHROPLUS %	Nifty 50 %	Difference pp
120 sessionssince 9 Apr	₹552.30	▲ +18%	▼ −5.7%	+23
60 sessionssince 8 Jul	₹639.55	▲ +1.5%	▼ −6.1%	+7.6
20 sessionssince 2 Sept	₹692.73	▼ −6.3%	▼ −6.2%	−0.08
5 sessionssince 24 Sept	₹709.47	▼ −8.5%	▼ −2.8%	−5.7
1 sessionsince 30 Sept	₹659.77	▼ −1.6%	▼ −0.88%	−0.76

Averages of the closeclose against each average

5-session average: ₹668.55close −2.9% from it
20-session average: ₹717.43close −9.5% from it
50-session average: ₹701.51close −7.5% from it

Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average

Average true range, 14: ₹274.1% of the close
Average day's range, 20: ₹233.6% of the close
Volume against 20 sessions: 0.33×2.4 L vs 7.3 L average

Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell

Realised volatility, 20: 36%≈ ±2.3% a session · moved more than that on 5 of 20
Realised volatility, 60: 34%≈ ±2.1% a session · moved more than that on 15 of 60
Beta to Nifty, 60: 0.68moved with Nifty on 32 of 60 sessions

Up and down sessionscloses above and below the previous close

Last 20 sessions: 8 up · 12 downof 20
Last 60 sessions: 27 up · 33 downof 60
Best session, 250: ▲ +10%15 May
Worst session, 250: ▼ −6.0%23 Mar

Nephrocare Health Services Limited is in 1 NSE index

Nifty IPO

0 bulletins on NEPHROPLUS

The desk has not written about Nephrocare Health Services Limited yet. The tape carries every bulletin as it is published.

About Nephrocare Health Services Limited

exchange masters as of 18 Sept 2026 · classification by BSE

Company: Nephrocare Health Services Limited
Exchange: NSE · BSE 544647, group B
Listed on NSE: 17 Dec 2025
Classification: Healthcare › Healthcare Services › Healthcare Service Provider
Index: BSE 1000
Face value: ₹2 a share
ISIN: INE428V01029
Sessions on record: 196
Price source: NSE UDiFF bhavcopy · end of day · delayed
Filings: NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed: 1 Oct, 09:16 pm IST
Bulletins: 0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.